MAP3K7 and pneumoconiosis: The reduction of TAK1 prevents lung inflammation in pneumoconiosis and reduces monosodium urate-induced inflammation as well as obesity-linked inflammation18,27,28; however, its biological function was little reported in neurological lesion especially in SCI.